CD79A and COVID-19: It is likely that the bridging antigen format and the use of antigen competition for the IgG and IgA assays, select for higher affinity antibodies resulting in improved accuracy for discriminating between pre-pandemic and COVID-19 samples (34), but potentially also reflects affinity maturation due to somatic hypermutation in the weeks following priming.